Fig. 1From: Comparison of regional citrate anticoagulation and nafamostat mesylate anticoagulation during plasma exchange for children at high bleeding risk: a retrospective studyOverview of patient selection. PE: plasma exchange; RCA: regional citrate anticoagulation; NM: nafamostat mesylateBack to article page